Bank of America just raised its EUR/USD forecast
Investing.com -- BofA Securities has downgraded ASR Nederland to “neutral” from “buy,” citing limited upside potential after a sharp rally in the stock this year.
The brokerage lifted its price objective to €63 from €61 but said the valuation has now caught up with peers, leaving little room for further surprises.
ASR shares have risen 35% in 2025, including a 10% gain since July, outpacing the sector by 12%.
At the new price objective, the stock offers about 6% total return, which analysts said is roughly in line with the industry average. The stock closed at €61.08 on August 20, just below the revised target.
The downgrade comes even as the insurer continues to report strong capital and operating results.
ASR’s Solvency II ratio stood at 203% in the first half of 2025, above expectations, and analysts forecast it will climb to 222% by 2026.
Operating capital generation reached €721 million in the first half, beating consensus by 4%, driven mainly by the life insurance segment.
Despite those gains, analysts said the outlook for excess capital returns is increasingly anticipated by the market, reducing the chance for upside surprises.
Earnings guidance remains solid. Management expects operating capital generation to exceed the €1.35 billion 2026 target, while BofA forecasts €1.42 billion.
Still, reported net profit in the first half was weaker than expected at €130 million, compared with consensus of €500 million, due to market volatility and a revaluation of Aegon’s book following its acquisition.
“ASR is a high-quality business, and we continue to see upside to capital return, but valuation has caught up (9x P/OCG, 7.8% total yield) and room to surprise becomes more limited,” the brokerage said.